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Abstract
We previously showed that rhesus macaques neonatally infected with simian immu-
nodeficiency virus (SIV) do not develop SIV encephalitis (SIVE) and maintain low 
brain viral loads despite having similar plasma viral loads compared to SIV-infected 
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adults. We hypothesize that differences in myeloid cell populations that are the 
known target of SIV and HIV in the brain contribute to the lack of neonatal suscep-
tibility to lentivirus-induced encephalitis. Using immunohistochemistry and immu-
nofluorescence microscopy, we examined the frontal cortices from uninfected and 
SIV-infected infant and adult macaques (n = 8/ea) as well as adults with SIVE (n 
= 4) to determine differences in myeloid cell populations. The number of CD206+ 
brain perivascular macrophages (PVMs) was significantly greater in uninfected in-
fants than in uninfected adults and was markedly lower in SIV-infected infants 
while microglia numbers were unchanged across groups. CD206+ PVMs, which pro-
liferate after infection in SIV infected adults, did not undergo proliferation in in-
fants. While virtually all CD206+ cells in adults are also CD163+, infants have a dis-
tinct CD206 single-positive population in addition to the double-positive population 
commonly seen in adults. Notably, we found that more than 60% of these unique 
CD206+CD163− PVMs in SIV-infected infants were positive for cleaved caspase-3, 
an indicator of apoptosis, and that nearly 100% of this subset were concomitantly 
positive for the necroptosis marker receptor interacting protein kinase-3 (RIP3). 
These findings show that distinct subpopulations of PVMs found in infants undergo 
programmed cell death instead of proliferation following SIV infection, which may 
lead to the absence of PVM-dependent SIVE and the limited size of the virus reser-
voir in the infant brain.
Keywords: apoptosis, CD206, HIV, macrophage, necroptosis, perivascular 
macrophage. 
Introduction 
Children with perinatally acquired HIV infection can manifest HIV 
encephalopathy defined by neurodevelopmental delay, impaired brain 
growth or a decline in motor and cognitive function (22). However, 
HIV-infected infants and children show lower brain viral loads and 
have a lower incidence of HIV encephalitis (HIVE), the pathological 
correlate of HIV-associated dementia, compared with adults (1, 5, 
12–14, 23–25). Studies in macaques infected with simian immuno-
deficiency virus (SIV), a premier animal model for studying HIV in-
fection, have confirmed these observations, finding very low levels 
of SIV RNA and no encephalitic lesions in the brains of SIV-infected 
infant macaques (4, 26). This lack of susceptibility to encephalitis 
in perinatally infected infants could be explained by possible differ-
ences between neonatal and adult brain myeloid cells, for example, in 
terms of their susceptibility to HIV/ SIV infection. Brain myeloid cells 
are a heterogeneous population of mononuclear cells primarily made 
up of microglia and brain macrophages (10, 11). While microglia are 
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spread throughout the brain parenchyma behind the blood-brain bar-
rier (BBB), perivascular macrophages (PVMs), the major contributor 
to encephalitic lesion formation, are located in the perivascular space 
around vessels and are most likely to come into contact with infiltrat-
ing viral particles (6, 7). 
We have previously shown that SIV infection in adult macaques 
induces a phenotypic switch of brain PVMs from CD206+CD163+ to 
CD206−CD163+, but the phenotypic switch in PVMs is unknown in 
infants (8). Additionally, CD206+ PVMs are known to proliferate in 
the brain after SIV infection of adult macaques, but no data exist con-
cerning their proliferation status in infants (7). While there is no evi-
dence of apoptosis in the brains of HIV/SIV-infected adults, cell death 
of PVMs would provide a reasonable explanation for the low brain vi-
ral loads and lack of encephalitic lesion formation in SIV-infected in-
fants. Therefore, we sought to investigate brain myeloid cell popula-
tions in uninfected infant macaques and track their response to SIV 
infection in relation to known shifts observed in the adult brain. We 
found that, unlike adults, there was no proliferation of neonatal PVMs 
in association with SIV infection. Interestingly, we observed a signifi-
cant drop in the number of CD206+ PVMs in the neonatal brain after 
SIV infection, which corresponds to a massive necroptosis of unique 
CD206+CD163− PVMs in SIV-infected neonates. As necroptosis, un-
like apoptosis, induces inflammation, this suggests that necroptosis-
induced anti-retroviral inflammation in the brain may contribute to 
cognitive impairment and neurodevelopmental delays in HIV-infected 
infants and children. 
Materials and methods 
Animals 
A total of 36 rhesus macaques (Macaca mulatta) were used in this 
retrospective study and divided into the following five groups based 
on infection status and age: uninfected infants (n = 8), SIV-infected 
infants (Infant SIV, n = 8), uninfected adults (n = 8), SIV-infected 
adults without encephalitis (Adult SIV, n = 8) and SIV-infected adults 
with encephalitis (Adult SIVE, n = 4) (Table 1). Infant macaques were 
defined as animals less than 1-year old at necropsy while adults were 
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determined to be greater than 3 years of age, but less than 12 years of 
age at necropsy. All animals were housed at the Tulane National Pri-
mate Research Center (TNPRC) in accordance with Tulane University’s 
Institutional Animal Care and Use Committee regulation and TNPRC 
end point policies. Infected groups were intravenously infected with 
SIVmac251. Five-μm-thick formalin-fixed paraffin-embedded (FFPE) 
frontal cortex brain tissue sections were cut from archival brain tissue 
Table 1. Animals used in study. 
Animal Infection status  Age at necropsy         Duration of infection 
11A472* Uninfected  4 days  N/A 
12A006* Uninfected  189 days N/A 
11A527*  Uninfected  8 days N/A 
15A524* Uninfected  182 days  N/A 
15A233  Uninfected  0 days  N/A 
15A202  Uninfected 0 days N/A 
15A164 Uninfected  0 days  N/A 
16A076  Uninfected  0 days  N/A 
11A490* SIV 37 days 37 days 
11A067*  SIV  245 days 154 days 
15A331*  SIV 47 days 47 days 
11A521* SIV  364 days 261 days 
11A489  SIV 77 days  76 days 
12A611  SIV 66 days  62 days 
15A516  SIV  200 days 64 days 
12A005  SIV 84 days  84 days 
11A014* Uninfected  4.77 years  N/A 
11A023*  Uninfected  4.69 years N/A 
11A313* Uninfected  5.02 years  N/A 
14A325*  Uninfected 4.09 years N/A 
11A635  Uninfected  5.14 years N/A 
14A342  Uninfected  3.23 years N/A 
14A351 Uninfected 4.04 years  N/A 
11A635  Uninfected  6.41 years N/A 
16A219*  SIVnoE  9.86 years 22 days 
16A229* SIVnoE  6.16 years  37 days 
16A230  SIVnoE 7.11 years  37 days 
16A320* SIVnoE  5.30 years  37 days 
16A323*  SIVnoE 5.26 years  40 days 
16A239  SIVnoE  6.13 years  471 days 
11A837 SIVnoE  8.28 years  224 days 
12A602 SIVnoE  6.31 years  493 days 
10A067  SIVE  5.7 years  79 days 
11A554  SIVE  10.28 years  98 days 
11A562  SIVE 5.51 years  69 days 
09A778  SIVE 3.51 years 119 days 
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blocks and examined. SIVE status was determined through the pres-
ence of SIV Gag proteins, accumulation of macrophages and the pres-
ence of multinucleated giant cells (MNGCs) in the brain. In an at-
tempt to understand the physiological implications of age-dependent 
pathogenesis of SIV, only non-ART treated animals were selected for 
this study. 
Immunohistochemistry 
All 36 animals were stained using semi-quantitative, single label 
immunohistochemistry (IHC) with the antibodies listed in Table 2. 
HLA-DR was used as an activated cell marker, P2RY12 was used as a 
microglia marker, CD206 was used as a PVM marker and MAC387 as 
an infiltrating macrophage marker. 
Frontal cortex sections were incubated at 60°C overnight before 
undergoing de-paraffinization and rehydration in a series of xylene 
and ethanol baths. Citrate-based Antigen Unmasking Solution (Vec-
tor Laboratories, Burlingame, CA) was used as a pretreatment in a 
microwave (1000 W) for 20 minutes. After a 20-minute cooling pe-
riod, slides were washed in Tris-buffered saline (TBS) with 0.05% 
Tween-20 and then treated with peroxidase block at room tempera-
ture for 10 minutes. Following another TBS/Tween-20 wash, sections 
were then blocked with 5% goat serum for 30 minutes before applica-
tion of the primary antibody for 1 h. After another TBS wash, second-
ary antibody was subsequently applied for 30 minutes, followed by a 
TBS/ Tween-20 wash. Amplification was achieved with Avidin- Bio-
tin Complex (ABC) for 30 minutes, followed by TBS/ Tween-20 wash 
and diaminobenzidine (DAB) application for 10 minutes. Sections then 
underwent Mayer’s Hematoxylin nuclear stain briefly before dehydra-
tion and coverslip mounting. Imaging of IHC slides was accomplished 
with a Nikon Coolscope digital microscope. All quantitated images 
were taken at 20× magnification, 70% aperture and +1.3% contrast. 
Immunofluorescence microscopy 
Semi-quantitative, double- and triple-label immunofluorescence 
(IF) was performed on the select groups of uninfected infant (n = 4), 
SIV-infected infant (n = 4), uninfected adult (n = 4) and SIV-infected 
adult macaques (n = 4) as denoted by asterisks in Table 1. CD206 and 
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CD163 were used to stain for PVMs, ionized calcium binding adaptor 
molecule 1 (Iba1) and P2RY12 were used to stain for microglia, Ki67 
was used to stain for recently proliferating cells, cleaved caspase-3 
was used to stain for cells undergoing apoptosis-specific cell death, 
and receptor-interacting protein kinase-3 (RIP3) was used to stain for 
cells undergoing necroptosis-specific cell death (Table 2). 
Frontal cortex sections were incubated at 60°C overnight before 
undergoing de-paraffinization and rehydration in a series of xylene 
and ethanol baths. Citrate-based Antigen Unmasking Solution (Vec-
tor Laboratories, Burlingame, CA) was used for pretreatment in a mi-
crowave (1000 W) for 20 minutes. After a 20-minute cooling period, 
slides were washed in phosphate buffered saline (PBS) containing 
0.2% fish skin gelatin (FSG) (PBS/FSG) and then permeabilized with 
PBS/FSG containing 0.1% Triton X-100 at room temperature for 1 h. 
Following another PBS/FSG wash, sections were then blocked with 
5% goat or horse serum for 30 minutes before application of the first 
primary antibody for 1 h. After another PBS/FSG wash, secondary 
antibody conjugated with either Alexa Fluor 488 or 594 (Molecular 
Probes) was diluted 1:500 and subsequently applied for 1 h followed 
by a PBS/FSG wash. Additional primary and secondary antibodies 
were applied as described previously. DAPI (4’,6-diamidino-2-phenyl-
indole) nuclei stain (Acros Organics) was applied on specified sections 
for 5 minutes. Quenching with CuSO4 for 45 minutes took place fol-
lowing completion of the staining process. Slides were then washed 
with deionized water and coverslip mounted using Aqua-Mount aque-
ous mounting medium (Thermo Scientific). 
Table 2. Antibodies used in the study. 
Target  Clone  Source  Cat #  IHC dilution  IF dilution 
CD163  10D6  Thermo MS-1103-S  N/A  1:20 
CD163  EPR4521 Epitomics 3659-1  N/A  1:100 
CD206 C-10  Santa Cruz 2 76232 1:500  1:50 
CD206  5C11  Abnova H00004360-M02  1:500  1:50 
Cleaved caspase-3 5A1E Cell signaling  9664  N/A 1:200 
HLA-DR LN3  BioLegend  327002 1:2000 N/A 
Ki67  SP6 Vector VP-RM04  N/A  1:10 
MAC387  MAC387  Thermo MS-148-P0  1:500 N/A 
P2RY12 pAb  Sigma Aldrich HPA014518 1:2000 N/A 
RIP3 p Ab  Abcam  Ab56164  N/A  1:40 
SIVmac251 p28  3F7  Fitzgerald  10-002201  N/A 1:200 
Bohannon,  Wang,  et  al .  in  Brain  Pathology  30  (2020)      7
IF microscopy images were taken with Zeiss Axio Observer .Z1 flu-
orescent microscope with either 20× or 40× objectives or a Zeiss 880 
Laser scanning confocal microscope with a 100× emersion oil objec-
tive. The capture and merging of Axio images was completed with 
Zeiss AxioVision 4.9.1 edition. Confocal images were captured and 
merged using ZenBlack and ZenBlue programs. All images within one 
quantification were taken with the same microscope and software us-
ing the same settings. Normalization of images to remove background 
was done where appropriate. 
Quantitative analysis 
Quantitative analysis was completed using ImageJ. For IHC images, 
ImageJ was used to evaluate percent area of positive staining relative 
to total area of the image using standardized thresholds for all images 
within the quantification. For IF images, ImageJ was used to obtain 
cell counts after thresholds were set to isolate positive cells and single 
and double stained population counts were then confirmed manually. 
While gray and white matter were quantified separately for the 
majority of IHC images, they were combined for all IF quantification. 
Only frontal cortex was examined in this study to eliminate potential 
differences in myeloid cell population proportions in different brain 
regions. We considered that infants might have an increased number 
of cells per field due to differences in cellular density, but an IHC nu-
clei count of each animal revealed no statistically significant differ-
ences in cellular density between infants and adults in grey matter or 
white matter individually, or combined (Figure S1A). For this reason, 
we decided not to normalize groups with a cellular density coefficient 
and all data is represented without regard to this factor. 
NanoString nCounter analysis 
FFPE frontal cortex 5-um sections (4/animal), from a total of 
twelve, six uninfected pediatric (3 male, 3 female) and six SIV-in-
fected (3 male, 3 female), pediatric rhesus macaques, were digested 
with a Qiagen FFPE RNeasy Kit. The procedure was performed fol-
lowing manufacturer’s instructions at the greater than 2 section vol-
umes using Qiagen Deparaffinization Solution (Qiagen). These sam-
ples were run on a NanoString nCounter Flex with a non-human 
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primate immunology panel. Data were normalized with nSolver 4.0. 
Fold changes and P-values are presented 
Statistical analysis 
Statistical analysis was performed by a Ph.D. biostatistician (J.L.). 
SAS® software 9.4 Version was used for data analysis. Individual sta-
tistical tests performed are indicated in figure legends. Statistical sig-
nificance is graphically represented with the following denotations: 
* denotes P < 0.05, ** denotes P < 0.01, *** denotes P < 0.001 and 
**** denotes P < 0.0001. 
Results 
Changes in myeloid cell populations after SIV infection in infants 
and adults 
Since brain myeloid cells are targets of HIV/SIV infection and are 
key players in lentiviral neuropathogenesis, we hypothesized that in-
fant brain myeloid cells may be different from those of adults. We 
posit that possible differences between neonatal and adult brain my-
eloid cells in normal uninfected macaques as well as their differential 
responses to SIV infection would contribute to lack of encephalitis in 
SIV-infected infant macaques. We set out to examine protein expres-
sion of HLA-DR, P2RY12, CD206 and MAC387 in the frontal cortices of 
infants and adults with and without SIV infection by semi-quantita-
tive IHC to measure the myeloid cell population levels in each group. 
Since infants do not show histological signs of SIV encephalitis [e.g., 
presence of multinucleated giant cells (MNGCs) and accumulation of 
infected macrophages], we stratified SIV infected adults into two sub-
groups according to the absence or presence of encephalitis (SIVnoE 
vs. SIVE). While Iba1 is a commonly used marker for IHC identification 
of microglia, in this study the purinergic receptor P2RY12 was used as 
a more selective marker for microglia as this shows a little to no affin-
ity for non-microglia activated macrophages in infected animals, but 
was highly colocalized with Iba1+ microglia in all animals (Figure S1). 
No significant differences in HLA-DR or P2RY12 expression were found 
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among any of the groups in grey or white matter, suggesting that HLA-
DR+ cells and microglia are unlikely to play a significant role in the 
neuropathogenesis of pediatric SIV infection (Figure S2A–D). Inves-
tigation using infiltrating macrophage marker MAC387 showed that 
only SIVE adults had significantly elevated levels of MAC387+ cells, 
suggesting that infiltrating macrophages are not the key myeloid cell 
population that is differentially regulated in infants (Figure S2E). The 
numbers of CD206+ PVMs in both grey and white matter, however, 
were significantly higher in uninfected infants than any other groups 
(Figure 1). Notably, there were significantly lower numbers of CD206+ 
cells with infection in pediatric animals indicating change in neonatal 
PVM populations in response to infection (Figure 1). 
Infant PVMs show the same degree of phenotypic switch as 
observed for adult PVMs after SIV infection 
Based upon our previous research on PVM response to SIV infec-
tion in adults, we initially hypothesized that the decrease in CD206+ 
cell populations after infection could be due to a phenotypic change of 
CD206+CD163+ PVMs to a CD206−CD163+ phenotype (8). IF exam-
ination with antibodies to CD206, CD163 and DAPI revealed a signif-
icant increase in CD163 single-positive cells in both infant and adult 
infected groups with a corresponding loss of CD206/CD163 double-
positive cells (Figure 2). There was, however, no significant differ-
ence between the change in population proportions between infants 
and adults, indicating that the phenotype switching seen in infants 
is consistent with what is seen in adults and may not account for the 
differences in pathologies observed (Figure 2E). 
Infant PVMs do not undergo proliferation after SIV infection 
We then focused on the proliferation levels of infant PVMs after 
infection to determine whether this could be a factor in the reduced 
replication of SIV in the brains of infected infants (7). We performed 
multi-label IF with antibodies to CD206, Ki67 proliferation marker 
and DAPI, and found that infants did not show increased levels of 
Ki67+CD206+ cells after infection as seen in adults (Figure 3). An in-
vestigation of PVM proliferation after SIV infection found that nuclear 
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Figure 1. Infant brains contain a very large number of CD206+ PVMs, which de-
creases after infection. IHC staining using an antibody against CD206 was used to 
study PVM levels across groups in grey matter (A) and white matter (B). In grey mat-
ter, uninfected infants had significantly more CD206 staining than infant SIV (P = 
0.0229), uninfected adults (P = 0.0012) and adult SIVnoE (P = 0.0064) groups (C). 
In white matter, uninfected infants had significantly more CD206 staining than in-
fant SIV (P = 0.0008), uninfected adults (P = 0.0002), adult SIVnoE (P = 0.0004) 
and adult SIVE (P = 0.0390) groups (D). A three-way ANOVA with Tukey- Kramer 
post-hoc analysis was performed (C,D). 
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Figure 2. A portion of CD206+CD163+ PVMs become CD206−CD163+ after SIV in-
fection. Triple-label IF for CD206 (green), CD163 (red) and DAPI (blue) revealed an 
increase in the CD206−CD163+ subpopulation after SIV infection in both infants 
(A,B) and adults (C,D). The CD206− CD163+ subpopulation among CD163+ PVMs in-
creased significantly in between uninfected and SIV-infected infants (+, P = 0.0354) 
and uninfected and SIVnoE adults (*, P = 0.0209) (E). A Kruskal-Wallis test for Wil-
coxon score was performed on each set of data (E). 
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Figure 3. Infants do not show proliferation of PVMs after infection as found in adults. 
Triple-label IF for CD206 (green), Ki67 (red) and DAPI (blue) demonstrates an in-
crease in Ki67+CD206+ proliferating PVMs in adult SIVnoE compared to all other 
groups (A–D). The percent of Ki67- positive cells out of total CD206+ PVMs was sig-
nificantly increased in adult SIVnoE compared to uninfected infants (P < 0.0001), 
infant SIV (P < 0.0001) and uninfected adults (P = 0.0003) (E). Manual counting of 
CD206+CD163−, CD206+CD163+ and CD206−CD163+ cells showed a significant de-
crease in the number of CD206- and/or CD163-positive PVMs in infant SIV compared 
to uninfected infants (P = 0.0120) (F). A three-way ANOVA analysis was performed 
with Tukey-Kramer post-hoc analysis (E) and a one-tailed t-test was performed (F). 
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staining of Ki67 was found in CD206+CD163+ cells in the brain of 
SIVnoE and SIVE adults, but that Ki67 staining was not observed in 
CD206−CD163+ cells or in any PVMs in the brain of SIV-infected in-
fants (Figure S3A–C). The apparent lack of detectable proliferation of 
PVMs in infected infants would impede lesion formation within the 
infant brain, but does not independently account for the massive de-
crease in CD206+ cells after infection. Total CD206+ and/or CD163+ 
cell counts in uninfected infant vs. SIV-infected infants showed a sig-
nificant decrease in PVMs in SIV-infected infants which, barring loss 
of both PVM markers, could indicate cell death (Figure 3F).We then 
focused on the proliferation levels of infant PVMs after infection to 
determine whether this could be a factor in the reduced replication of 
SIV in the brains of infected infants (7). We performed multi-label IF 
with antibodies to CD206, Ki67 proliferation marker and DAPI, and 
found that infants did not show increased levels of Ki67+CD206+ cells 
after infection as seen in adults (Figure 3). An investigation of PVM 
proliferation after SIV infection found that nuclear staining of Ki67 
was found in CD206+CD163+ cells in the brain of SIVnoE and SIVE 
adults, but that Ki67 staining was not observed in CD206−CD163+ 
cells or in any PVMs in the brain of SIV-infected infants (Figure S3A–
C). The apparent lack of detectable proliferation of PVMs in infected 
infants would impede lesion formation within the infant brain, but 
does not independently account for the massive decrease in CD206+ 
cells after infection. Total CD206+ and/or CD163+ cell counts in unin-
fected infant vs. SIV-infected infants showed a significant decrease in 
PVMs in SIV-infected infants which, barring loss of both PVM mark-
ers, could indicate cell death (Figure 3F). 
Increased apoptosis of PVMs in infants 
We began by identifying distinct subpopulations of PVMs in each 
study group and found that a unique subclass of CD206+CD163− 
PVMs were present in infants, but not in adults (Figures 4A and 
S3). The numbers and proportions of each PVM subpopulation 
can be viewed in Figure S3D. To determine whether this unique 
CD206+CD163- subpopulation are selectively infected in infant 
brains, we examined SIVmac251 p28 immunoreactivity in the brain 
of SIV-infected infants and found that SIV p28 staining is localized 
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Figure 4. Increased apoptosis of infected CD206+ cells in infants, but not in adults, 
contributes to the decrease in total PVMs after infection. Double IF for CD206 and 
CD163 showed a significant population of CD206+CD163− cells present in unin-
fected infants and not seen in uninfected adults (P = 0.0038) (A). Triple IF for 
CD206 (red) CD163 (green) and SIVp28 (blue) shows the presence of SIV p28 protein 
in CD206+CD163− cells (arrowheads) (B). Double IF for CD206 (red)  [continued] 
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in CD206+CD163- cells, but not in CD163+ cells in acutely infected 
infants (Figure 4B). We also demonstrated the presence of SIV DNA 
in CD206+ cells in the brain of infected infants (Figure S4). To in-
vestigate the fate of these PVMs after SIV infection in infants, we 
measured the percent of CD206+ cells undergoing apoptosis in un-
infected and SIV infected infants (Figure 4C,D). Cleaved caspase-3 
was used as a marker to measure apoptosis in these cells due to its 
high reliability and decreased susceptibility to influence from for-
malin fixation post-mortem interval discrepancies as found with 
terminal deoxynucleotidyl transferase dUTP nick end labeling (TU-
NEL) (3). Triple-label IF revealed more than 60% of CD206+CD163− 
PVMs are undergoing apoptosis in SIV infants compared to less than 
10% in uninfected infants (Figure 4E,F). Consistent with prior liter-
ature in humans (2, 27), neither SIV-infected nor uninfected adults 
showed any evidence of cleaved caspase-3-positive PVMs (Figure 
S5A,B). Similarly, CD206+CD163+ and CD206−CD163+ cells showed 
no evidence of undergoing apoptosis in any groups (data not shown). 
This indicates that the unique CD206+/CD163− population is dying 
after infection in SIV-infected infants. 
A unique CD206+CD163− PVM phenotype that is found in 
infants, but not in adults, undergoes necroptosis and apoptosis 
simultaneously during SIV infection 
We then performed further investigation of mechanisms of pro-
grammed cell death in this unique CD206+CD163− PVM population to 
determine if necroptosis plays a role in the loss of PVMs in SIV-infected 
infants. Triple-label IF for CD206, CD163 and the necroptosis marker 
RIP3 showed that nearly 100% of CD206+CD163− cells in SIV-infected 
infants were RIP3+ while less than 3% were undergoing necroptosis 
and cleaved caspase-3 (green) shows a significant increase in the number of CD206+ 
cells with cleaved caspase-3+ staining in SIV-infected infants compared to uninfected 
infants (C,D). Triple-label IF for CD206 (red), CD163 (blue) and cleaved caspase-3 
(green) shows CD206+CD163− cells to be undergoing apoptosis in SIV-infected in-
fants (E). Infant SIV had significantly more CD206+CD163− cells undergoing apop-
tosis compared to uninfected infants (P < 0.0001) (F). A one-tailed t-test was per-
formed (A,F). 
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in uninfected infants (Figure 5). No evidence of RIP3-positive staining 
was found in uninfected or SIV-infected adults (Figure S5C,D). RIP3 
was found exclusively in this distinct CD206+CD163− subpopulation 
and neither CD206+CD163+ nor CD206−CD163+ cells showed RIP3- 
positive staining. The constitutive expression of necroptosis markers 
within CD206+CD163− cells taken in conjunction with the finding 
that more than 60% of these cells are undergoing apoptosis suggests 
Figure 5. CD206+/CD163− cells undergo necroptosis in the SIV-infected infant 
brain. Double-label IF for CD206 (red) and RIP3 (green) shows a significant in-
crease in the number of CD206+ cells with RIP3+ staining in SIV-infected infants 
compared to uninfected infants (A,B). Triple IF for CD206 (red), CD163 (blue) 
and RIP3 (green) shows that CD206+CD163- cells are the only cell type under-
going necroptosis in SIV-infected infants (C). Infant SIV had significantly more 
CD206+CD163− cells undergoing necroptosis compared to uninfected infants (P < 
0.0001) (D). A one-tailed t-test was performed (D). 
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that more than half of CD206+CD163− cells are undergoing apoptosis 
and necroptosis concurrently in a dual programmed cell death mech-
anism. Massive programmed cell deaths of PVMs in SIV-infected in-
fants, but not in SIV-infected adults, provides one possible explana-
tion for the low tissue viral loads observed in the brain of neonatally 
infected infants. 
Type I Interferon response is upregulated in association with 
necroptosis of PVMs in SIV-infected infants 
Further investigation of the inflammatory profile of SIV-infected in-
fants compared to uninfected infants via NanoString nCounter mRNA 
analysis found that of the 770 investigated genes, only 30 were signif-
icantly differentially regulated (Table S1). Of the significantly differ-
entially regulated genes, 40% were indicative of an upregulation in a 
type I interferon (IFN) signaling (Table 3). Previous studies investi-
gating macrophage necroptosis have indicated an association between 
type-I IFN-medicated inflammation and RIP3-induced necroptosis, but 
further research is required to fully understand the nature of this re-
lationship (16, 18, 20, 21). Upregulation of the IFN pathway and con-
comitant widespread necroptosis of a unique subpopulation of PVMs 
Table 3. With SIV infection, the expression of 12 type I interferon response genes 
was significantly upregulated in the infant brain, when measured using the 
NanoString nCounter platform. 
Probe Name  SIV vs. UI P-value of: SIV vs. UI 
STAT2 1.83  0.01791774 
IRF7 2.37  0.02581042 
OAS3 2.69 0.03784646 
DDX58  3.33 0.003002 
IFIT2  3.33 0.01535743 
BST2  3.5  0.00574702 
OAS2 4.07 0.00645026 
IFI44  4.2 0.00807947 
STAT1  5.23 0.00273646 
IFIT3  7.01 0.01235302 
IFIT1  7.33 0.00186525 
MX1  12.63 0.00227231 
Note: Significantly differentially regulated genes associated with the interferon sig-
naling pathway. 
Bohannon,  Wang,  et  al .  in  Brain  Pathology  30  (2020)      18
in SIV-infected infants provide one possible explanation for the clin-
ical encephalopathy observed in HIV pediatric infection despite the 
lack of traditional pathologies observed in adults. 
Discussion 
We have previously reported that infant macaques neonatally in-
fected with SIV do not develop SIVE (4). In that report, we attributed 
this lack of susceptibility to SIVE in infants to the possible differences 
in brain myeloid cells in neonates vs. adults. In the current study, we 
describe for the first time a unique subset of PVMs in the neonatal 
macaque brain that is positive for CD206 but negative for CD163. We 
further demonstrate this PVM subset is prone to undergo necroptosis 
and apoptosis. To our knowledge, this is the first in vivo evidence for 
necroptosis in primates. 
This unique CD206+CD163− subpopulation of PVMs in the brain of 
infant rhesus macaques represents a key physiological difference in 
infant and adult neuroimmunology which could prove crucial in un-
derstanding pediatric immune responses to neuro-invasive pathogens. 
In response to pathogens, CD206+CD163+ PVMs have been shown to 
induce an influx of neutrophils to the infected area releasing granu-
locytes which are important for the clearance of pathogens, but the 
functionality of CD206+CD163− PVMs in immune regulation is un-
known (19). CD163+ PVMs are also shown to drive lesion formation 
in HIV/SIV infection in part because they begin to proliferate after 
becoming infected, but the reduced levels of proliferation and result-
ing cell death of CD206+CD163− PVMs after SIV infection is the most 
likely contributing factor to the lack of encephalitic lesion forma-
tion and low tissue viral loads found in SIV- and HIV infected infant 
brains (10, 17). In the present study, we were able to detect SIV DNA 
in CD206+ PVMs in the brain of in SIV-infected infant brain. More-
over, SIV p28 expression was infrequently detected at low levels and 
localized exclusively in CD206+CD163− PVMs in acutely SIV-infected 
infants. We propose that this is likely due to a lack of viral replica-
tion in CD206+CD163− cells because they undergo programmed cell 
death prior to the production of more viral particles preventing ac-
tive replication. The current study demonstrates the presence of an 
infant specific CD206+CD163− PVM subpopulation. Improving our 
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understanding of this unique infant PVM population could provide an 
underlying mechanism for fundamental differences in neuro-immune 
response to pathogenic insult in infants. 
While no evidence of significant cell death is found in the brains of 
SIV-infected adults, CD206+CD163− PVMs in SIV-infected infants un-
dergo both apoptosis and necroptosis simultaneously. This phenom-
ena has been implied in the past and shown in vitro and in artificial 
models, but to our knowledge, this is the first endogenous in vivo ev-
idence of dual activation of apoptosis and necroptosis (9, 15). While 
the mechanism of dual activation is unclear, the pro-inflammatory 
nature of necroptosis would make it undesirable in the immune-priv-
ileged environment of the brain, and an attempt to rescue the pro-
cess through apoptosis would produce a lower inflammatory profile. 
Thus, we propose that upon exposure to HIV/SIV, CD206+CD163− 
PVMs undergo dual activation of necroptosis and apoptosis eliminat-
ing themselves and any viral particles resulting in a decreased tissue 
viral load and preventing the buildup of PVMs which would cause le-
sion formation. 
Previous studies have shown an association between IFN signaling 
and macrophage necroptosis, but the exact mechanism by which this 
is occurring is unclear. Some studies suggest that constitutively high 
levels of IFN signaling can initiate the necroptosis pathway in macro-
phages (16, 20). Other findings suggest that viral infection can lead 
to activation of macrophage necroptosis which may induce the up-
regulation of several inflammatory pathways including IFNs (18, 21). 
It is currently unclear what mechanisms are driving the association 
between IFN signaling and necroptosis in our model, but our find-
ings suggest that elevated IFN signaling and massive necroptosis of 
CD206+CD163− PVMs are central to the neuropathogenesis of HIV/
SIV infection in infants. 
Understanding how the infant brain is naturally suppressing brain 
viral reservoirs may be the first step in devising a mechanism by 
which this elimination could be achieved in adults and help us improve 
our treatment of pediatric patients infected with HIV. In light of this 
understanding and with relevance to HIV progressive encephalopathy 
in HIV-infected infants and children, determining whether necropto-
sis-induced “anti-retroviral” inflammation in the brain is the cause of 
this central nervous system (CNS) disease of unknown etiology is im-
portant. In conclusion, differential responses to SIV infection in infant 
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and adult myeloid cell populations provide an explanation for the dif-
ference in CNS pathological findings. Necroptosis in the neonatal hu-
man brain needs to be characterized and assessed to increase our un-
derstanding of pediatric HIV infection and CNS disease. 
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Supplementary Figure 1  Examination of the number of nuclei by Meyers Hematoxylin 
staining showed no significant differences despite age or infection status in the total number of 
microglia present in combined grey and white matter (a). Double-label immunofluorescence for 
Iba1 (red) and P2RY12 (green) microglial markers demonstrate high levels of colocalization as 
well as an Iba1+/P2RY12− macrophage cell (white arrow) (b). A three-way ANOVA test was 




Supplementary Figure 2  IHC staining using antibodies against HLA-DR, P2RY12, and 
MAC387 were used to study myeloid cell levels across groups in grey matter (a,c) and white 
matter (b,d). No statistical significance was found between groups for HLA-DR or P2RY12 (a-
d). MAC387 was measured using combined grey and white matter, and Adult SIVE was found to 
have significantly more MAC387-positive cells than uninfected infants (p=0.0391), infant SIV 
(p=0.0084), uninfected adult (p=0.0002), adult SIVnoE (p=0.0009), and infected infants were 
found to be significantly higher than uninfected adults (p=0.0394), but not significantly different 
from uninfected infants (0.6811) (e). A three-way ANOVA with Tukey-Kramer post-hoc 
analysis was performed (a-e).  
  
 
Supplementary Figure 3  Triple-label IF for CD206 (red), CD163 (blue), and Ki67 (green) 
shows that CD206+CD163+ cells in SIV-infected adults were Ki67+, but that Ki67 staining was 
observed in neither CD206− PVMs in adults nor any PVMs in infants (a-c). Using triple-label IF 
for CD206, CD163, and DAPI, the number among total CD206+ and/or CD163+ perivascular 
macrophages, CD206+CD163+, CD206−CD163+, CD206+CD163− cells were counted from 15 
frames for each animal. No statistical analysis was performed for (d), which is solely provided 
for reference.   
 
Supplementary Figure 4  In situ hybridization for SIV DNA (SIV DNAscope) followed by 
CD206 IHC staining in the frontal cortex of an SIV-infected pediatric animal demonstrated the 
presence of vDNA in CD206+ PVMs. Briefly, SIV vDNA was detected using ACD SIV sense 
probe according to the manufacturer’s instructions (a). The whole tissue sections were digitized 
after vDNA detection, and CD206 IHC staining was subsequently performed on the same section 
with Dako polymer detection kit. 
 
Supplementary Figure 5  Double IF for CD206 (red) and cleaved caspase-3 (green) shows no 
CD206+ cells with cleaved caspase-3+ staining in uninfected adults or Adult SIVnoE groups 
(a,b). Double-label IF for CD206 (red) and RIP3 (green) shows no CD206+ cells with RIP3-
positive staining in uninfected adults or Adult SIVnoE groups (c,d). 
 
  
Supplementary Table 1 
Probe Name SIV vs. UI P value of: SIV vs. UI 
CD40LG -3.51 0.013214 
CHIT1 -3.42 0.0320432 
IL2 -3.36 0.00467145 
FPR2 -3.09 0.01898056 
TWIST2 -2.53 0.02607519 
MMP3 -2.34 0.04177755 
LAG3 -2.22 0.03104966 
LILRB4 -2.15 0.0422738 
CCL4 -1.85 0.04994285 
CCND3 1.46 0.03992456 
CTNNB1 1.53 0.01829085 
ATG10 1.78 0.01744916 
STAT2 1.83 0.01791774 
IRF7 2.37 0.02581042 
OAS3 2.69 0.03784646 
PSMB9 2.75 0.01193465 
TAP2 2.95 0.00436252 
HLA-A 3.14 0.01314097 
DDX58 3.33 0.003002 
IFIT2 3.33 0.01535743 
TAP1 3.41 0.01592444 
BST2 3.5 0.00574702 
HLA-B 3.78 0.00340413 
OAS2 4.07 0.00645026 
B2M 4.11 0.00516471 
IFI44 4.2 0.00807947 
STAT1 5.23 0.00273646 
IFIT3 7.01 0.01235302 
IFIT1 7.33 0.00186525 
MX1 12.63 0.00227231 
 
A NanoString non-human primate immunology mRNA panel was used to evaluate frontal cortex 
tissue from SIV-infected and uninfected infants (n=6/ea). Probes were normalized with nSolver 
and fold change values with a p-value less than 0.05 were selected. Genes with a negative fold 
change are higher in uninfected infants, while genes with a positive fold change are higher in 
SIV-infected infants than uninfected infants.  
 
